14th Asia-Pacific Breast Cancer Summit 2026 shared a post on LinkedIn:
“What does the latest evidence say about how much surgery is enough in early breast cancer?
As part of the Best of San Antonio Breast Cancer Symposium at APBCS 2026, Prof. Ava Kwong (Hong Kong) will present key surgical insights that are shaping modern local therapy decisions.
Session: Local Therapy (Surgery)
Date: Friday, 6 February 2026
Time: 14:05 – 14:35 (Malaysia Time)
This talk will unpack pivotal data from major international trials, including:
– Axillary surgery outcomes in patients with 1–3 sentinel node macrometastases (INSEMA trial)
– Evidence supporting omission of sentinel lymph node biopsy in select T1–2 node-negative patients (Dutch BOOG 2013-08 trial)
– Comparing more versus less invasive axillary staging after neoadjuvant chemotherapy (AXSANA / EUBREAST 3(R))
– Impact of preoperative breast MRI on locoregional recurrence in early-stage disease (Alliance A011104 / ACRIN 6694)
A must-attend session for clinicians navigating surgical de-escalation while maintaining oncologic safety.
Register now to be part of these critical conversations in breast cancer care.”
